| Product Code: ETC7647695 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Central Nervous System (CNS) Stimulants Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Central Nervous System (CNS) Stimulants Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Central Nervous System (CNS) Stimulants Market - Industry Life Cycle |
3.4 Israel Central Nervous System (CNS) Stimulants Market - Porter's Five Forces |
3.5 Israel Central Nervous System (CNS) Stimulants Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.6 Israel Central Nervous System (CNS) Stimulants Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Israel Central Nervous System (CNS) Stimulants Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Israel Central Nervous System (CNS) Stimulants Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Israel Central Nervous System (CNS) Stimulants Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Central Nervous System (CNS) Stimulants Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in Israel |
4.2.2 Growing awareness about mental health and the importance of CNS stimulants |
4.2.3 Technological advancements in CNS stimulant medications |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for CNS stimulant drugs in Israel |
4.3.2 High cost associated with CNS stimulant medications |
4.3.3 Potential side effects and concerns regarding the long-term use of CNS stimulants |
5 Israel Central Nervous System (CNS) Stimulants Market Trends |
6 Israel Central Nervous System (CNS) Stimulants Market, By Types |
6.1 Israel Central Nervous System (CNS) Stimulants Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Israel Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 Israel Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Phendimetrazine, 2021- 2031F |
6.1.4 Israel Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Phentermine, 2021- 2031F |
6.1.5 Israel Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Methamphetamine, 2021- 2031F |
6.1.6 Israel Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Dextroamphetamine, 2021- 2031F |
6.1.7 Israel Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Central Nervous System (CNS) Stimulants Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Israel Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Major Depressive Disorder, 2021- 2031F |
6.2.3 Israel Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Anxiety Disorders, 2021- 2031F |
6.2.4 Israel Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Attention Deficit Hyperactivity Disorder, 2021- 2031F |
6.2.5 Israel Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Central Nervous System (CNS) Stimulants Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Israel Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Israel Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Injectable, 2021- 2031F |
6.3.4 Israel Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Central Nervous System (CNS) Stimulants Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Israel Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Israel Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 Israel Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 Israel Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Israel Central Nervous System (CNS) Stimulants Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Israel Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Israel Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 Israel Central Nervous System (CNS) Stimulants Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Israel Central Nervous System (CNS) Stimulants Market Import-Export Trade Statistics |
7.1 Israel Central Nervous System (CNS) Stimulants Market Export to Major Countries |
7.2 Israel Central Nervous System (CNS) Stimulants Market Imports from Major Countries |
8 Israel Central Nervous System (CNS) Stimulants Market Key Performance Indicators |
8.1 Number of clinical trials and research studies conducted on CNS stimulants in Israel |
8.2 Adoption rate of new CNS stimulant therapies by healthcare providers |
8.3 Patient adherence and compliance rates to CNS stimulant treatment plans |
9 Israel Central Nervous System (CNS) Stimulants Market - Opportunity Assessment |
9.1 Israel Central Nervous System (CNS) Stimulants Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.2 Israel Central Nervous System (CNS) Stimulants Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Israel Central Nervous System (CNS) Stimulants Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Israel Central Nervous System (CNS) Stimulants Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Israel Central Nervous System (CNS) Stimulants Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Central Nervous System (CNS) Stimulants Market - Competitive Landscape |
10.1 Israel Central Nervous System (CNS) Stimulants Market Revenue Share, By Companies, 2024 |
10.2 Israel Central Nervous System (CNS) Stimulants Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here